新一代投资公司
需要帮忙?联系
电话  +8621 8024 5997 联系我们

我们使用Cookie来个性化内容和广告,提供社交媒体功能并分析我们的流量。我们还与社交媒体,广告和分析合作伙伴共享有关您使用我们网站的信息,这些合作伙伴可能会将其与您提供给他们的其他信息或他们从您使用其服务中收集的信息相结合。如果您继续使用我们的网站,即表示您同意我们的cookie。

Canadian medical cannabis producer Tilray launches IPO

Canadian medical cannabis producer Tilray launches IPO

NASDAQ now offers some unusual shares: Tilray, a global leader in medical cannabis research, cultivation, processing, and distribution, launched the first IPO in this sphere. Tilray is offering 9 million shares of Class 2 at the opening price of $23,05 per share. The company intends to grant underwriters a 30-day over-allotment option to purchase up to 1,350,000 of additional shares.

The ticker of the share is NASDAQ:TLRY and it’s already available in the default list of the stock section in EXANTE Trading Platform.

Tilray is the first GMP-certified medical cannabis producer to supply cannabis products to tens of thousands of patients, physicians, pharmacies, hospitals, and researchers. With its branches located in Europe, USA and Canada, it operates all over the world from Chile to New Zealand.

The information in this text is provided to you for informational purposes only and should not be regarded as an offer or solicitation of an offer to buy or sell any investments or related services that may be referenced here.

Canadian medical cannabis producer Tilray launches IPO
阅读更多
由专业人士创建。 为专业人士。
最近的代表办事处:  EXANTE LTD. (伦敦分行)
1前街,伦敦
EC2Y 9DT
英格兰, +356 2015 0000